Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
np-g2-044 (2 trials)
Esophageal Neoplasms (Phase 1)
Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (1 total)